Edwards Lifesciences (EW) PT Lowered to $85 at Mizuho Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Total darkness, then sunset as full eclipse wows spectators in Spain
- Burry doubles down on Nebius short after stock surges 34% on earnings
Edwards Lifesciences (EW) tumbles as guidance misses expectations
October 26, 2023 10:07 AM EDTEdwards Lifesciences (NYSE: EW) shares tumbled over 8% in after-hours trading after the company's latest earnings and guidance announcement disappointed investors and analysts alike.
After Wednesday's close, the company reported Q3 earnings of $0.59 per share, in line with the analyst estimate of $0.59. Revenue for the quarter was also in line, coming in at $1.48 billion, although that was a 12%... More
